000 01484 a2200409 4500
005 20250515053311.0
264 0 _c20070306
008 200703s 0 0 eng d
022 _a1524-4563
024 7 _a10.1161/01.HYP.0000256530.39695.a3
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aNeumann, Jutta
245 0 0 _aSympathetic hyperactivity in hypertensive chronic kidney disease patients is reduced during standard treatment.
_h[electronic resource]
260 _bHypertension (Dallas, Tex. : 1979)
_cMar 2007
300 _a506-10 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAngiotensin II Type 1 Receptor Blockers
_xpharmacology
650 0 4 _aAngiotensin-Converting Enzyme Inhibitors
_xpharmacology
650 0 4 _aChronic Disease
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aHypertension
_xcomplications
650 0 4 _aKidney Diseases
_xetiology
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMuscles
_xinnervation
650 0 4 _aSympathetic Nervous System
_xdrug effects
700 1 _aLigtenberg, Gerry
700 1 _aKlein, Inge H T
700 1 _aBoer, Peter
700 1 _aOey, P Liam
700 1 _aKoomans, Hein A
700 1 _aBlankestijn, Peter J
773 0 _tHypertension (Dallas, Tex. : 1979)
_gvol. 49
_gno. 3
_gp. 506-10
856 4 0 _uhttps://doi.org/10.1161/01.HYP.0000256530.39695.a3
_zAvailable from publisher's website
999 _c16789149
_d16789149